<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d1 20130915//EN" "JATS-journalpublishing1.dtd">
<article article-type="case-report" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JKCVHL</journal-id>
<journal-title-group>
<journal-title>Journal of Kidney Cancer and VHL</journal-title>
<abbrev-journal-title>JKCVHL</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2203-5826</issn>
<publisher>
<publisher-name>Codon Publications</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">JKCVHL-11-023</article-id>
<article-id pub-id-type="doi">10.15586/jkcvhl.v11i3.342</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>CASE REPORT</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Clinical T1a Renal Cell Carcinoma with Solitary Diaphragmatic Metastasis in a Patient with von Hippel-Lindau Disease</article-title>
</title-group>
<contrib-group content-type="authors">
<contrib contrib-type="author"><name><surname>Hirai</surname> <given-names>Tadataka</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib> 
<contrib contrib-type="author" corresp="yes"><name><surname>Uka</surname> <given-names>Mayu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1"/></contrib> 
<contrib contrib-type="author"><name><surname>Iguchi</surname> <given-names>Toshihiro</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib> 
<contrib contrib-type="author"><name><surname>Yasui</surname> <given-names>Kazuya</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib> 
<contrib contrib-type="author"><name><surname>Kawabata</surname> <given-names>Takahiro</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib> 
<contrib contrib-type="author"><name><surname>Umakoshi</surname> <given-names>Noriyuki</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib> 
<contrib contrib-type="author"><name><surname>Tomita</surname> <given-names>Koji</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib> 
<contrib contrib-type="author"><name><surname>Matsui</surname> <given-names>Yusuke</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib> 
<contrib contrib-type="author"><name><surname>Kobayashi</surname> <given-names>Yasuyuki</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib> 
<contrib contrib-type="author"><name><surname>Araki</surname> <given-names>Motoo</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib> 
<contrib contrib-type="author"><name><surname>Hiraki</surname> <given-names>Takao</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib>
<aff id="aff1"><label>1</label>Department of Radiology, Okayama University Hospital, Okayama, Japan;</aff>
<aff id="aff2"><label>2</label>Department of Radiological Technology, Faculty of Health Sciences, Okayama University, Okayama, Japan;</aff>
<aff id="aff3"><label>3</label>Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan;</aff>
<aff id="aff4"><label>4</label>Department of Radiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University;</aff>
<aff id="aff5"><label>5</label>Department of Urology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><italic>Author for correspondence:</italic> Mayu Uka, Department of Radiology, Okayama University Hospital, Okayama, Japan. Email: <email>mayuuka3@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>02</day>
<month>08</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection"><year>2024</year></pub-date>
<volume>11</volume>
<issue>3</issue>
<fpage>23</fpage>
<lpage>26</lpage>
<history>
<date date-type="received"><day>14</day><month>04</month><year>2024</year></date> 
<date date-type="accepted"><day>19</day><month>07</month><year>2024</year></date> 
</history>
<permissions>
<copyright-statement><italic>Copyright:</italic> Hirai T., et al.</copyright-statement>
<copyright-year>2024</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p><italic>License:</italic> This open access article is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link></license-p>
</license>
</permissions>
<abstract>
<p>We report the case of a 38-year-old man with two von Hippel-Lindau disease-associated T1a renal cell carcinomas (RCCs) (&#x003C;2 cm in diameter) which developed into a 2.5-cm solitary diaphragmatic metastatic tumor. After diagnosis using percutaneous biopsy, the diaphragmatic metastasis and two RCCs were treated by laparoscopic resection and percutaneous cryoablation, respectively. One year after treatment, the patient survived without local recurrence or distant metastasis. This report describes a rare case of RCC metastasis in VHL disease and its treatment.</p>
</abstract>
<kwd-group>
<kwd>Carcinoma</kwd>
<kwd>Diaphragm</kwd>
<kwd>Renal Cell</kwd>
<kwd>von Hippel-Lindau Disease</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p>Von Hippel-Lindau (VHL) syndrome is an inherited autosomal dominant disease with a prevalence of approximately 1 in 30,000 people. VHL is characterized by tumors occurring at multiple sites; these include renal cell carcinoma (RCC), pancreatic endocrine tumors, central neuroangioblastoma, and pheochromocytomas (<xref ref-type="bibr" rid="ref1">1</xref>). RCCs occur in approximately 70% of patients with VHL who survive until the age of 60 years (<xref ref-type="bibr" rid="ref2">2</xref>). Furthermore, multiple and/or bilateral tumors are frequently reported in patients with RCCs (<xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref4">4</xref>). Moreover, the risk of metastasis in patients with VHL-associated RCC is correlated with the tumor size, with small RCCs (&#x003C;3&#x2013;4 cm) associated with a lower risk of metastasis. Follow-up is recommended for patients with small RCCs to avoid treatment-induced deterioration in renal function (<xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref4">4</xref>). Here, we report a rare case of clinical T1a RCC &#x003C;2 cm in size that developed into a solitary diaphragmatic metastasis.</p>
</sec>
<sec id="S2" sec-type="cases">
<title>Case Report</title>
<p>Here, we report the case of a 38-year-old man with VHL diagnosed by genetic testing who presented to our hospital with small right renal nodules, suspected to be RCC. The nodules gradually increased over time and were detected during periodic follow-ups with plain computed tomography (CT) and magnetic resonance imaging (MRI). Therefore, he was referred to our department for further evaluation and treatment of the renal nodules. He was asymptomatic and presented with no other diseases and normal laboratory data. Contrast-enhanced CT and MRI revealed nodules (1.8&#x00D7;1.5 cm and 1.1&#x00D7;1.0 cm in diameter, respectively) on the ventral side of the right kidney (<xref ref-type="fig" rid="F1">Figure 1</xref>). He also had a nodule (2.5&#x00D7;1.7 cm in diameter) contiguous with the diaphragm and compressing the liver from the outside (<xref ref-type="fig" rid="F1">Figures 1</xref> and <xref ref-type="fig" rid="F2">2</xref>). The renal nodules had cystic degeneration, heterogeneous early enhancement, and delayed washout, suggesting clear-cell RCC. Moreover, the nodule contiguous with the diaphragm had a contrast pattern similar to that of renal lesions (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<fig id="F1" orientation="portrait" position="float">
<label>Figure 1:</label>
<caption><p>Dynamic computed tomography (CT) images (A and B: corticomedullary phase, C: delayed phase, oblique images). CT images revealed nodules with septal enhancement and cystic degeneration, 1.8 cm (circle) and 1.1 cm (dot circle) in diameter on the right renal upper pole. A nodule with early enhancement and delayed washout of 2.5 cm in diameter (arrow) bordering the liver surface was also detected.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JKCVHL-11-023-g001.tif"/>
</fig>
<fig id="F2" orientation="portrait" position="float">
<label>Figure 2:</label>
<caption><p>Plain MRI (fat-suppression T2WI). (A) Coronal MRI 6 months before resection revealed a 1.5-cm extrahepatic nodule. (B) Coronal MRI 2 months before resection revealed that the nodule had increased to 2.5 cm in diameter. The nodule was contiguous with the diaphragm and was compressing the liver from outside.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JKCVHL-11-023-g002.tif"/>
</fig>
<p>CT-guided biopsies were performed on a larger renal nodule and the diaphragmatic nodule. Both were diagnosed as clear-cell RCC (Fuhrman grade 1 and undiagnosed Fuhrman grade, respectively). After consultation with a multidisciplinary team, including urologists, radiologists, and hepatobiliary surgeons, the diaphragmatic lesion was resected as a solitary metastasis, while percutaneous cryoablation (PCA) was performed for the renal tumors to preserve renal function. Laparoscopic resection of the diaphragmatic lesion was performed, and intraoperative findings revealed no peritoneal dissemination; the tumor had grown solitarily and subependently from the diaphragm (<xref ref-type="fig" rid="F3">Figure 3</xref>) and compressed the extrahepatic side. The diaphragm muscle layer and the tumor were resected. Pathologically, the diaphragmatic tumor was a 2.5-cm nodular lesion with pale cytoplasmic tumor cells with abundant blood vessels and fibrous stroma, closely resembling a renal biopsy specimen, leading to the diagnosis of clear-cell RCC (Fuhrman grade 2) diaphragmatic metastasis. The transected margins were negative.</p>
<fig id="F3" orientation="portrait" position="float">
<label>Figure 3:</label>
<caption><p>Surgical image. The metastatic tumor (arrow) was solitary and grew subependently from the diaphragm, compressing the right lobe of the liver.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JKCVHL-11-023-g003.tif"/>
</fig>
<p>Forty days after surgery, CT-guided PCA was performed completely and safely on the two RCCs using an argon- and helium-based cryoablation system (Visual-ICE; Boston Scientific, Marlborough, MA, USA) with three 17-gauge cryoprobes (Ice Sphere, Boston Scientific). Two freeze-thaw cycles of PCA were performed for each tumor, and ice ball formation was monitored by CT to ensure a safety margin of at least 6 mm around the tumor. One year after the treatment, the patient was alive without local recurrence or metastasis on follow-up imaging.</p>
</sec>
<sec id="S3" sec-type="discussion">
<title>Discussion</title>
<p>To date only one study has reported a diaphragmatic metastasis arising from T1a RCC; however, the said report did not discuss the size of the RCC (<xref ref-type="bibr" rid="ref5">5</xref>). The RCCs in this case were small (maximum size of 1.8 cm) with a Fuhrman grade of 1, suggesting a low probability of metastasis. More importantly, solitary diaphragmatic metastases are rare.</p>
<p>In a previous report involving 142 patients, VHL-associated RCC metastasized to other organs less frequently than nonhereditary RCC, with 12.7% of patients with RCC developing metastasis during a mean follow-up of 68.2 months. The mean tumor size during metastasis detection was 8.2 cm (5.6&#x2013;14.0) and the sites of metastasis included the lung, lymph nodes, abdomen, and brain, as in the case of nonhereditary RCC (<xref ref-type="bibr" rid="ref3">3</xref>). The size of the renal tumor has been reported to be associated with the risk of metastasis, and VHL-associated RCC &#x003C;3 cm in size rarely metastasize (<xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref4">4</xref>). Moreover, the growth rate is a risk factor for metastasis, and lesions growing &#x003E;1 cm per year have a significantly higher risk of metastasis (<xref ref-type="bibr" rid="ref3">3</xref>). Furthermore, VHL-associated RCCs tend to have a lower histological grade than nonhereditary RCCs (<italic>p</italic> = 0.0011) (<xref ref-type="bibr" rid="ref6">6</xref>). These findings indicated that VHL-associated RCC have an inherently lower metastatic potential.</p>
<p>In another study including 1,913 patients with nonhereditary clinical T1a RCC, the most common metastatic sites were the lung, bone, liver, and adrenal gland, in that order. The overall metastatic rate was 3.1%, with a positive correlation between tumor size and metastatic risk (<italic>p</italic> &#x003C; 0.001) (<xref ref-type="bibr" rid="ref7">7</xref>). Kato et al. reported that in 198 postoperative follow-up patients with pathological T1a RCC, the metastatic rate was significantly higher in patients with Fuhrman grades 3 and 4 RCCs than in those with grades 1 and 2 RCCs (<xref ref-type="bibr" rid="ref8">8</xref>).</p>
<p>Colon, liver, uterine, and ovarian cancers metastasize more frequently to the diaphragm (<xref ref-type="bibr" rid="ref9">9</xref>). Although surgical resection is not indicated in cases of multiple diaphragmatic metastases, it may be indicated in cases of solitary metastases (<xref ref-type="bibr" rid="ref9">9</xref>). Diaphragmatic metastasis can be induced by hematogenous metastasis or peritoneal dissemination with intraperitoneal tumors prone to peritoneal dissemination via the peritoneal stomata (<xref ref-type="bibr" rid="ref10">10</xref>). In this patient with untreated T1a RCCs, dissemination through the peritoneal cavity was quite unlikely, and the tumor was thus considered a hematogenous metastasis.</p>
<p>CT and MRI are useful in the diagnosis of diaphragmatic tumors, as the associations between the diaphragm and liver are easily detected. The identification of the boundary between the diaphragmatic tumor and the liver as a fatty tissue layer by CT (especially volume-rendering CT) (<xref ref-type="bibr" rid="ref11">11</xref>) and the inferior phrenic artery as a feeding artery by Doppler ultrasonography (<xref ref-type="bibr" rid="ref12">12</xref>) has been reported to be useful in the preoperative diagnosis of diaphragmatic tumors. In this patient, the extrahepatic tumor was easily diagnosed using coronal axis MRI. However, the growth rate was faster than that of the primary lesion, and distinguishing a diaphragmatic primary tumor, such as a solitary fibrous tumor, from renal cancer metastasis before biopsy was difficult.</p>
</sec>
<sec id="S4" sec-type="conclusions">
<title>Conclusion</title>
<p>We encountered two clinical T1a RCCs that developed a rare solitary diaphragmatic metastasis in a patient with VHL. The correct diagnosis was made preoperatively, and RCCs and metastatic lesions were controlled with local treatment.</p></sec>
</body>
<back>
<sec id="S5" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare no potential conflicts of interest with respect to research, authorship, and/or publication of this article.</p>
</sec>
<fn-group>
<fn id="fn1"><p><italic>How to cite:</italic> Hirai T., et al. Clinical T1a Renal Cell Carcinoma with Solitary Diaphragmatic Metastasis in a Patient with von Hippel-Lindau Disease, J Kidney Cancer VHL. 2024; 11(3): 23&#x2013;26.</p></fn></fn-group>
<ref-list>
<ref id="ref1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Binderup</surname> <given-names>MLM</given-names></string-name>, <string-name><surname>Galanakis</surname> <given-names>M</given-names></string-name>, <string-name><surname>BudtzJ&#x00F8;rgensen</surname> <given-names>E</given-names></string-name>, <string-name><surname>Kosteljanetz</surname> <given-names>M</given-names></string-name>, <string-name><surname>Luise Bisgaard</surname> <given-names>M</given-names></string-name></person-group>. <article-title>Prevalence, birth incidence, and penetrance of von Hippel-Lindau disease (vHL) in Denmark</article-title>. <source>Europen Journal of Human Genetics</source>. <year>2017</year>;<volume>25</volume>(<issue>3</issue>):<fpage>301</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2016.173</pub-id></mixed-citation></ref>
<ref id="ref2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Maher</surname> <given-names>ER</given-names></string-name>, <string-name><surname>Yates</surname> <given-names>JR</given-names></string-name>, <string-name><surname>Harries</surname> <given-names>R</given-names></string-name>, <string-name><surname>Benjamin</surname> <given-names>C</given-names></string-name>, <string-name><surname>Harris</surname> <given-names>R</given-names></string-name>, <string-name><surname>Moore</surname> <given-names>AT</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Clinical features and natural history of von Hippel-Lindau disease</article-title>. <source>Quarterly Journal of Medical Science</source>. <year>1990</year>;<volume>77</volume>(<issue>283</issue>):<fpage>1151</fpage>&#x2013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1093/qjmed/77.2.1151</pub-id></mixed-citation></ref>
<ref id="ref3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Peng</surname> <given-names>X</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>J</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>J</given-names></string-name>, <string-name><surname>Peng</surname> <given-names>S</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>S</given-names></string-name>, <string-name><surname>Ma</surname> <given-names>K</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Natural history of renal tumors in von Hippel-Lindau disease: A large retrospective study of Chinese patients</article-title>. <source>Journal of Medical Genetics</source>. <year>2019</year>;<volume>56</volume>(<issue>6</issue>):<fpage>380</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1136/jmedgenet-2018-105567</pub-id></mixed-citation></ref>
<ref id="ref4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Binderup</surname> <given-names>MLM</given-names></string-name>, <string-name><surname>Smerdel</surname> <given-names>M</given-names></string-name>, <string-name><surname>Borgwadt</surname> <given-names>L</given-names></string-name>, <string-name><surname>Nielsen</surname> <given-names>SSB</given-names></string-name>, <string-name><surname>Madsen</surname> <given-names>MG</given-names></string-name>, <string-name><surname>M&#x00F8;ller</surname> <given-names>HU</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>von Hippel-Lindau disease: Updated guideline for diagnosis and surveillance</article-title>. <source>European Journal of Medical Genetics</source>. <year>2022</year>;<volume>65</volume>(<issue>8</issue>):<fpage>104538</fpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2022.104538</pub-id></mixed-citation></ref>
<ref id="ref5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Assouad</surname> <given-names>J</given-names></string-name>, <string-name><surname>Banu</surname> <given-names>E</given-names></string-name>, <string-name><surname>Brian</surname> <given-names>E</given-names></string-name>, <string-name><surname>Pham</surname> <given-names>DN</given-names></string-name>, <string-name><surname>Dujon</surname> <given-names>A</given-names></string-name>, <string-name><surname>Foucault</surname> <given-names>C</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Strategies and outcomes in pulmonary and extrapulmonary metastases from renal cell cancer</article-title>. <source>European Journal of Cardio-Thoracic Surgery</source>. <year>2008</year>;<volume>33</volume>(<issue>5</issue>):<fpage>794</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejcts.2008.01.045</pub-id></mixed-citation></ref>
<ref id="ref6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname> <given-names>J</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>L</given-names></string-name>, <string-name><surname>Qiu</surname> <given-names>J</given-names></string-name>, <string-name><surname>Li</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Wu</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>C</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Natural history of von Hippel-Lindau disease-associated and sporadic clear cell renal cell carcinoma: A comparative study</article-title>. <source>Journal of Cancer Research Clinical Oncology</source>. <year>2021</year>;<volume>148</volume>(<issue>10</issue>):<fpage>2631</fpage>&#x2013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1007/s00432-021-03806-0</pub-id></mixed-citation></ref>
<ref id="ref7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname> <given-names>H</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>JK</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>K</given-names></string-name>, <string-name><surname>Kwak</surname> <given-names>C</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>HH</given-names></string-name>, <string-name><surname>Byun</surname> <given-names>SS</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Risk of metastasis for T1a renal cell carcinoma</article-title>. <source>World Journal of Urology</source>. <year>2016</year>;<volume>34</volume>(<issue>4</issue>):<fpage>553</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1007/s00345-015-1659-4</pub-id></mixed-citation></ref>
<ref id="ref8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kato</surname> <given-names>T</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>C</given-names></string-name>, <string-name><surname>Masumori</surname> <given-names>N</given-names></string-name>, <string-name><surname>Yamasaki</surname> <given-names>T</given-names></string-name>, <string-name><surname>Matsumoto</surname> <given-names>H</given-names></string-name>, <string-name><surname>Baba</surname> <given-names>M</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>T1a renal cell carcinoma with metastasis: Japanese society of renal cancer retrospective multi-institute results</article-title>. <source>Anticancer Research</source>. <year>2023</year>;<volume>43</volume>:<fpage>4061</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.21873/anticanres.16595</pub-id></mixed-citation></ref>
<ref id="ref9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Toyoda</surname> <given-names>T</given-names></string-name>, <string-name><surname>Suzuki</surname> <given-names>H</given-names></string-name>, <string-name><surname>Nakajima</surname> <given-names>T</given-names></string-name>, <string-name><surname>Iwata</surname> <given-names>T</given-names></string-name>, <string-name><surname>Matsuoka</surname> <given-names>A</given-names></string-name>, <string-name><surname>Nishikimi</surname> <given-names>K</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Successful diagnosis of an occult fallopian tube carcinoma detected from the diaphragm metastasis</article-title>. <source>General Thoracic and Cardiovascular Surgery</source>. <year>2018</year>;<volume>66</volume>(<issue>8</issue>):<fpage>484</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1007/s11748-017-0881-y</pub-id></mixed-citation></ref>
<ref id="ref10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Abu-Hijleh</surname> <given-names>MF</given-names></string-name>, <string-name><surname>Habbal</surname> <given-names>OA</given-names></string-name>, <string-name><surname>Moqattash</surname> <given-names>ST</given-names></string-name></person-group>. <article-title>The role of the diaphragm in lymphatic absorption from the peritoneal cavity</article-title>. <source>Journal of Anatomy</source>. <year>1995</year>;<volume>186</volume> <issue>Pt 3</issue><fpage>453</fpage>&#x2013;<lpage>67</lpage>.</mixed-citation></ref>
<ref id="ref11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gruzdev</surname> <given-names>IS</given-names></string-name>, <string-name><surname>Blokhin</surname> <given-names>IA</given-names></string-name>, <string-name><surname>Lednev</surname> <given-names>AN</given-names></string-name>, <string-name><surname>Pechetov</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Makov</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Esakov</surname> <given-names>YS</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Metastasis of endometrial cancer to right hemidiaphragm: A case report</article-title>. <source>International Journal of Surgery Case Reports</source>. <year>2019</year>; <volume>60</volume>:<fpage>363</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijscr.2019.06.028</pub-id></mixed-citation></ref>
<ref id="ref12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ota</surname> <given-names>H</given-names></string-name>, <string-name><surname>Kawai</surname> <given-names>H</given-names></string-name>, <string-name><surname>Yagi</surname> <given-names>N</given-names></string-name>, <string-name><surname>Ogawa</surname> <given-names>J</given-names></string-name></person-group>. <article-title>Successful diagnosis of diaphragmatic solitary fibrous tumor of the pleura by preoperative ultrasonography</article-title>. <source>General Thoracic Cardiovascular Surgery</source>. <year>2010</year>;<volume>58</volume>(<issue>9</issue>):<fpage>485</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1007/s11748-009-0551-9</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>